Pear Therapeutics Explores Strategic Options; May Seek Reorganization If Unable To Complete Transaction

Pear Therapeutics Inc PEAR is engaged in a process to explore strategic alternatives.
The company has engaged MTS Health Partners, L.P., to act as its exclusive financial advisor to assist in evaluating potential alternatives.
Pear is exploring the potential for an acquisition, company sale, merger, divestiture of assets, licensing, or other strategic transactions and/or seeking additional financing as part of its process.
If the company cannot complete a transaction, it may be required to seek a reorganization, liquidation, or other restructuring.
Last month, Pear Therapeutics expanded its collaboration with BrightView Health, an addiction treatment provider offering evidence-based, outpatient treatment programs.
This initiative is designed to provide access to reSET and reSET-O.
reSET is intended to provide cognitive behavioral therapy as an adjunct to a contingency management system. It is used as a monotherapy for adult patients with substance use disorder.
reSET-O is used with buprenorphine-based medication-assisted treatment for patients 18 or older with opioid use disorder.
Price Action: PEAR shares are down 18.48% at $0.4835 on the last check Friday.
Photo Via Company